Halozyme Therapeutic (NQ: HALO )

45.25 USD -2.06 (-4.35%)

Official Closing Price Updated: 7:58 PM EST, Feb 26, 2021 Add to My Watchlist

Price and Volume

Volume	2,200,200
Open	47.45
Bid (Size)	45.25 (1)
Ask (Size)	46.35 (1)
Prev. Close	47.31
Today's Range	45.11 - 48.63
52wk Range	12.71 - 56.40
Shares Outstanding	143,965,620
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $700 Million of Convertible Senior Notes due 2027

February 24, 2021

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company"), a leader in converting IV biologics to subcutaneous delivery, today announced the pricing of $700 million aggregate principal...

Are These Top Health Care Stocks Worth Watching Ahead Of March?

February 25, 2021

Performance

YTD	+6.70%	+6.70%
1 Month	-3.81%	-3.81%
3 Month	+12.48%	+12.48%
6 Month	+59.11%	+59.11%
1 Year	+123.24%	+123.24%

More News

Halozyme Therapeutics, Inc. Announces Proposed Offering of $500 Million of Convertible Senior Notes due 2027

February 23, 2021

Halozyme Reports Fourth Quarter 2020 Results And Full Year 2020 Results

February 23, 2021

Halozyme To Host Fourth Quarter And Full Year 2020 Financial Results Webcast And Conference Call

February 10, 2021

Why Halozyme Therapeutics Is Trading 14% Higher Today

February 24, 2021

Recap: Halozyme Therapeutics Q4 Earnings

February 23, 2021

Halozyme Therapeutics Inc (HALO) Q4 2020 Earnings Call Transcript

February 23, 2021

Halozyme Therapeutics Larger Than S&P 500 Component PVH

February 08, 2021

The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants

February 25, 2021

80 Biggest Movers From Yesterday

February 25, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.